Topics

Eli Lilly’s Christi Shaw to Take Over Helm of Kite Pharma

20:00 EDT 11 Jul 2019 | BioSpace

At Kite, Shaw will focus on turning around the company's flagship CAR-T treatment Yescarta, as well as focus on the development of other cancer-targeting cell therapies.

Original Article: Eli Lilly’s Christi Shaw to Take Over Helm of Kite Pharma

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly’s Christi Shaw to Take Over Helm of Kite Pharma"

Quick Search

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...